113 related articles for article (PubMed ID: 11089512)
1. Methodologic issues in acute migraine clinical trials.
Lipton RB
Neurology; 2000; 55(9 Suppl 2):S3-7. PubMed ID: 11089512
[TBL] [Abstract][Full Text] [Related]
2. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
3. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
4. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
Goadsby PJ
Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
[TBL] [Abstract][Full Text] [Related]
5. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study.
Gawel M; Aschoff J; May A; Charlesworth BR;
Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607
[TBL] [Abstract][Full Text] [Related]
6. Early treatment in migraine: how strong is the current evidence?
Gendolla A
Cephalalgia; 2008 Sep; 28 Suppl 2():28-35. PubMed ID: 18715330
[TBL] [Abstract][Full Text] [Related]
7. What do patients want from acute migraine treatment?
Gallagher R
Cephalalgia; 2004; 24 Suppl 2():8-15. PubMed ID: 15595989
[TBL] [Abstract][Full Text] [Related]
8. Applying the benefits of the AwM study in the clinic.
Dodick DW
Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
[TBL] [Abstract][Full Text] [Related]
9. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine.
Sandrini G; Dahlöf CG; Mathew N; Nappi G
Int J Clin Pract; 2005 Nov; 59(11):1356-65. PubMed ID: 16236092
[TBL] [Abstract][Full Text] [Related]
10. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
11. Consistent efficacy, tolerability, and high levels of satisfaction with almotriptan 12.5 mg when used to treat multiple migraine attacks in routine clinical practice.
Diener HC
Headache; 2005 Jun; 45(6):624-31. PubMed ID: 15953293
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of early triptan therapy for migraine.
Láinez M
Cephalalgia; 2004; 24 Suppl 2():24-30. PubMed ID: 15595991
[TBL] [Abstract][Full Text] [Related]
13. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
[TBL] [Abstract][Full Text] [Related]
14. Almotriptan and zolmitriptan in the acute treatment of migraine.
Goadsby PJ; Massiou H; Pascual J; Diener HC; Dahlöf CG; Mateos V; Dowson AJ; Raets I; Cunha L; Färkkilä M; Manzoni GC
Acta Neurol Scand; 2007 Jan; 115(1):34-40. PubMed ID: 17156263
[TBL] [Abstract][Full Text] [Related]
15. Triptan nonresponder studies: implications for clinical practice.
Dodick DW
Headache; 2005 Feb; 45(2):156-62. PubMed ID: 15705122
[TBL] [Abstract][Full Text] [Related]
16. Acute drug treatment of migraine attack.
Narbone MC; Abbate M; Gangemi S
Neurol Sci; 2004 Oct; 25 Suppl 3():S113-8. PubMed ID: 15549517
[TBL] [Abstract][Full Text] [Related]
17. The use of rizatriptan in the treatment of acute, multiple migraine attacks.
Saper JR
Neurology; 2000; 55(9 Suppl 2):S15-8. PubMed ID: 11089514
[TBL] [Abstract][Full Text] [Related]
18. Sumatriptan and naproxen sodium for the acute treatment of migraine.
Smith TR; Sunshine A; Stark SR; Littlefield DE; Spruill SE; Alexander WJ
Headache; 2005 Sep; 45(8):983-91. PubMed ID: 16109111
[TBL] [Abstract][Full Text] [Related]
19. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the efficacy of migraine therapy.
Chawluk JB
Postgrad Med; 2000 Sep; 108(3 Suppl):16-21. PubMed ID: 19667526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
